US 11,896,590 B2
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof
Christopher U. Missling, New York, NY (US)
Assigned to ANAVEX LIFE SCIENCES CORP., New York, NY (US)
Filed by ANAVEX LIFE SCIENCES CORP., New York, NY (US)
Filed on Feb. 12, 2021, as Appl. No. 17/175,572.
Application 17/175,572 is a continuation of application No. 16/267,102, filed on Feb. 4, 2019, granted, now 10,933,062.
Application 16/267,102 is a continuation of application No. 15/340,311, filed on Nov. 1, 2016, granted, now 10,195,192, issued on Feb. 5, 2019.
Prior Publication US 2021/0196708 A1, Jul. 1, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/495 (2006.01); A61P 25/02 (2006.01)
CPC A61K 31/495 (2013.01) [A61P 25/02 (2018.01)] 20 Claims
 
1. A dosage form comprising a therapeutically effective amount of 1-(3-(4(((1R, 3S, 5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine (“AV1066”) or a pharmaceutically acceptable salt thereof,
wherein the therapeutically effective amount is to relieve or prevent pain in a subject in need thereof;
wherein the AV1066 is in the (+) form substantially absent the (−) form.